Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis
Anno:
2023
Background: This study aims to evaluate the prevalence and clinical significance of the right ventricular pulmonary arterial (RV-PA) uncoupling in patients with cardiac amyloidosis (CA). Methods: The study population consisted in 92 consecutive patients with CA (age 71.1±12.2 years, 71% males; 47% with immunoglobulin light chain (AL), 53% with…
A HEART OF STONE: A CASE OF APOLIPOPROTEIN A-I CARDIAC AMYLOIDOSIS TREATED WITH HEART TRANSPLANT
Anno:
2023
A 56-year-old woman was referred to our Unit for advanced heart failure refractory to pharmacological therapy with poor functional status (NYHA class IV, INTERMACS profile 4-5). She had a history of restrictive and hypokinetic cardiomyopathy secondary to autosomal dominant hereditary Apolipoprotein A-I (APOA1) amylodosis caused by Leu75Pro mutation, detected both in…
MARCHE REGIONAL NETWORK FOR CARDIAC AMYLOIDOSIS AND HYPERTOPHIC CARDIOMYOPATHY: INSIGHTS FROM 3-YEAR COLLABORATIVE EXPERIENCE.
Anno:
2023
Background and Methods: the management of patients with Cardiac Amyloidosis (CA) and Hypertrophic Cardiomyopathy (HCM) is complex and requires specific skills. Collaboration between centres remains essential because not all centres can perform complex diagnostic techniques (such as endomyocardial biopsy and mass spectrometry) or prescribe disease-modifying therapies, Therefore, in 2019 we created a…
Looking for red flags
Anno:
2023
Case report: a 81 years old man with systemic hypertension, dyslipidemia, past smoking habit, was admitted to the ER of our hospital with acute decompensated heart failure. Since July he complained of worsening of dyspnea and paroxysmal nocturnal dyspnea. His blood pressure was of 155/80 mmHg, the HR was of 78…